Table of Contents
Table 5-53: Monroe
Table 5-55: Morgan
| Primary Site | Incidence | Mortality | ||||||
|---|---|---|---|---|---|---|---|---|
| 2002 | 1998 - 2002 | 2002 | 1998 - 2002 | |||||
| Count | Rate | Count | Rate | Count | Rate | Count | Rate | |
| All Sites | 107 | 604.6 | 522 | 600.5 | 44 | 255.7 | 225 | 270.2 |
| Esophagus | * | # | 8 | 8.8** | * | # | 6 | 6.7** |
| Stomach | * | # | 4 | # | * | # | 1 | # |
| Colon excluding Rectum | 13 | 73.6** | 38 | 45.7 | * | # | 19 | 23.2** |
| Rectum and Rectosigmoid Junction | * | # | 13 | 14.5** | * | # | 0 | # |
| Liver | * | # | 3 | # | * | # | 2 | # |
| Pancreas | * | # | 15 | 16.9** | 6 | 33.5** | 16 | 17.7** |
| Lung and Bronchus | 29 | 167.6 | 97 | 114.5 | 20 | 113.6 | 80 | 94.7 |
| Melanoma of the Skin | * | # | 13 | 14.5** | * | # | 3 | # |
| Prostate | 26 | 144.6 | 169 | 192.7 | * | # | 23 | 30.9 |
| Urinary Bladder | 6 | 33.0** | 34 | 39.6 | * | # | 3 | # |
| Kidney and Renal Pelvis | * | # | 16 | 17.7** | * | # | 7 | 9.3** |
| Brain and Other Nervous System | * | # | 2 | # | * | # | 5 | 6.0** |
| Non-Hodgkin Lymphoma | 6 | 34.5** | 26 | 27.8 | 5 | 26.5** | 14 | 15.3** |
| Myeloma | * | # | 5 | 5.7** | * | # | 4 | # |
| Leukemia | 7 | 39.1** | 18 | 21.6** | * | # | 11 | 14.1** |
| Primary Site | Incidence | Mortality | ||||||
|---|---|---|---|---|---|---|---|---|
| 2002 | 1998 - 2002 | 2002 | 1998 - 2002 | |||||
| Count | Rate | Count | Rate | Count | Rate | Count | Rate | |
| All Sites | 85 | 384.9 | 428 | 384.5 | 35 | 153.6 | 181 | 151.9 |
| Colon excluding Rectum | 10 | 44.1** | 55 | 46.9 | * | # | 20 | 15.6 |
| Rectum and Rectosigmoid Junction | * | # | 14 | 12.1** | * | # | 7 | 6.1** |
| Liver | * | # | 3 | # | * | # | 2 | # |
| Pancreas | * | # | 11 | 8.9** | * | # | 10 | 7.8** |
| Lung and Bronchus | 8 | 35.5** | 48 | 41.7 | 8 | 36.0** | 37 | 31.5 |
| Melanoma of the Skin | * | # | 12 | 11.6** | * | # | 2 | # |
| Breast | 24 | 113.1 | 124 | 115.1 | 7 | 27.9** | 25 | 20.5 |
| Cervix Uteri | * | # | 10 | 11.1** | * | # | 6 | 6.2** |
| Corpus Uteri | 10 | 44.1** | 30 | 28.1 | * | # | 1 | # |
| Ovary | * | # | 12 | 11.1** | * | # | 14 | 11.7** |
| Urinary Bladder | * | # | 10 | 8.5** | * | # | 1 | # |
| Kidney and Renal Pelvis | * | # | 16 | 13.2** | * | # | 3 | # |
| Brain and Other Nervous System | * | # | 7 | 6.7** | * | # | 5 | 4.6** |
| Non-Hodgkin Lymphoma | * | # | 12 | 10.7** | * | # | 8 | 6.3** |
| Myeloma | * | # | 6 | 5.1** | * | # | 2 | # |
| Leukemia | * | # | 13 | 11.0** | * | # | 7 | 6.2** |
Rates are per 100,000; Age-adjusted, 2000 US Std Million Million.
* Fewer than 5 cases, number suppressed to protect confidentiality.
** Rates based on fewer than 20 cases are unstable.
# Rate cannot be calculated.
Source: Indiana State Department of Health - Indiana State Cancer Registry and the Epidemiology Resource Center, Data Analysis Team, July 2005
Table of Contents
Table 5-53: Monroe
Table 5-55: Morgan
